Novo Nordisk A/S (NVO)
NYSE: NVO
· Real-Time Price · USD
59.64
0.90 (1.53%)
At close: Oct 03, 2025, 3:59 PM
59.80
0.27%
After-hours: Oct 03, 2025, 07:58 PM EDT
1.53% (1D)
| Bid | 59.63 |
| Market Cap | 265.01B |
| Revenue (ttm) | 311.94B |
| Net Income (ttm) | 111.07B |
| EPS (ttm) | 3.92 |
| PE Ratio (ttm) | 15.21 |
| Forward PE | 1.96 |
| Analyst | Hold |
| Dividends | $1.68 |
| Ask | 59.78 |
| Volume | 14,289,639 |
| Avg. Volume (20D) | 17,737,020 |
| Open | 59.00 |
| Previous Close | 58.74 |
| Day's Range | 58.45 - 60.09 |
| 52-Week Range | 45.05 - 120.56 |
| Beta | 0.33 |
| Ex-Dividend Date | Aug 18, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for NVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNovo Nordisk A/S is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 days ago
+6.63%
Shares of several drugmakers are trading higher af...
Unlock content with
Pro Subscription
6 days ago
-0.2%
Novo Nordisk shares are trading lower after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and cut its price target from $59 to $47.
